Kaketsuken, Daiichi Sankyo deal

The Chemo-Sero Therapeutic Research Institute (Kaketsuken) granted Daiichi Sankyo non-exclusive rights to co-commercialize Kaketsuken's Bimmugen recombination adsorbed hepatitis B vaccine in Japan. ...